Subcellular Localization Determines the Protective Effects of Activated ERK2 against Distinct Apoptogenic Stimuli in Myeloid Leukemia Cells

Nuria Ajenjo, Estela Cañón, Isabel Sánchez‐Pérez, David Matallanas, Javier León, Rosario Perona, Piero Crespo

Journal of Biological Chemistry · 2004 · 57 citations · 70 references

DOIFull text

Open access

Concepts

Abstract

ERKs, mitogen-activated protein kinases, are well characterized as key mediators in the conveyance of signals that promote cell survival in cells of hemopoietic origin, a key factor in the upbringing of leukemogenesis. It is also well known that ERKs phosphorylate a wide array of substrates distributed throughout distinct cellular locations such as the nucleus, cytoplasm, and cell periphery, but the relative contribution of these compartmentalized signal components to the overall survival signal generated by activation of ERKs has yet to be established. To this end, we have utilized constitutively activated forms of ERK2, whose expression is restricted to the nucleus or to the cytoplasm, to investigate the consequences of compartmentalized activation of ERK in the survival of chronic myelogenous leukemia cells subjected to distinct apoptogenic stimuli. We show that cytoplasmic ERK2 activity protected against apoptosis caused by prolonged serum starvation, whereas ERK2 activation restricted to the nucleus antagonized apoptosis induced by the Bcr-Abl inhibitor STI571. On the other hand, neither cytoplasmic nor nuclear ERK2 activities were effective in counteracting apoptosis induced by UV light. These results demonstrate that the protective effects of ERK2 against defined apoptogenic stimuli are strictly dependent on the cellular localization where ERK activation takes place. Furthermore, we present evidence suggesting that the complex IκB-NFκB participates on ERK2-mediated survival mechanisms, in a fashion dependent on the cellular location where ERK2 is active and on the causative apoptogenic stimulus. ERKs, mitogen-activated protein kinases, are well characterized as key mediators in the conveyance of signals that promote cell survival in cells of hemopoietic origin, a key factor in the upbringing of leukemogenesis. It is also well known that ERKs phosphorylate a wide array of substrates distributed throughout distinct cellular locations such as the nucleus, cytoplasm, and cell periphery, but the relative contribution of these compartmentalized signal components to the overall survival signal generated by activation of ERKs has yet to be established. To this end, we have utilized constitutively activated forms of ERK2, whose expression is restricted to the nucleus or to the cytoplasm, to investigate the consequences of compartmentalized activation of ERK in the survival of chronic myelogenous leukemia cells subjected to distinct apoptogenic stimuli. We show that cytoplasmic ERK2 activity protected against apoptosis caused by prolonged serum starvation, whereas ERK2 activation restricted to the nucleus antagonized apoptosis induced by the Bcr-Abl inhibitor STI571. On the other hand, neither cytoplasmic nor nuclear ERK2 activities were effective in counteracting apoptosis induced by UV light. These results demonstrate that the protective effects of ERK2 against defined apoptogenic stimuli are strictly dependent on the cellular localization where ERK activation takes place. Furthermore, we present evidence suggesting that the complex IκB-NFκB participates on ERK2-mediated survival mechanisms, in a fashion dependent on the cellular location where ERK2 is active and on the causative apoptogenic stimulus. Most hemopoietic disorders exhibit a broad spectrum of molecular malfunctions that alter the mechanisms, one way or another, by which cells control critical processes such as proliferation, differentiation, and cell survival. Many of these alterations arise in components of the molecular circuitry through which external cues in the form of cytokines, growth factors, or hormones regulate the aforementioned biological processes. A large number of these faulty signaling intermediaries impinge, either directly or indirectly, on signal transduction pathways mediated by mitogen-activated protein kinases (MAPKs) 1The abbreviations used are: MAPK, mitogen-activated protein kinase; ERK, extracellular signal-regulated kinase; MEK, MAPK/ERK kinase; MBP, myelin basic protein; DTT, dithiothreitol; CML, chronic myelogenous leukemia; PARP, poly (ADP-ribose) polymerase; EMSA, electrophoretic mobility shift assay; PBS, phosphate-buffered saline; CREB, cAMP-response element-binding protein. 1The abbreviations used are: MAPK, mitogen-activated protein kinase; ERK, extracellular signal-regulated kinase; MEK, MAPK/ERK kinase; MBP, myelin basic protein; DTT, dithiothreitol; CML, chronic myelogenous leukemia; PARP, poly (ADP-ribose) polymerase; EMSA, electrophoretic mobility shift assay; PBS, phosphate-buffered saline; CREB, cAMP-response element-binding protein. and have profound effects on the biological outputs mediated by these signaling modules (1Pearson G. Robinson F. Gibson T.G. Xu B. Karandikar M. Berman K. Cobb M.H. Endocr. Rev. 2001; 22: 153-183Google Scholar). MAPKs are cytoplasmic serine/threonine kinases that are activated in response to a wide array of extracellular stimuli, including those that regulate cell proliferation, differentiation, cell survival, development, and inflammation. MAPKs are pivotal elements in the transduction of signals from the cell surface, acting as essential mediators in signaling cascades that include sequentially: MAPK kinase kinases, dual-specificity MAPK kinases, and MAPKs (1Pearson G. Robinson F. Gibson T.G. Xu B. Karandikar M. Berman K. Cobb M.H. Endocr. Rev. 2001; 22: 153-183Google Scholar). Extracellular signal-regulated kinases (ERKs) p44 ERK1 and p42 ERK2 MAPKs are activated in response to most, if not all, stimuli that promote proliferation and/or survival. Such activation is mainly achieved through a route that includes Raf-1 serine/threonine kinase and MEK1/2 dual specificity kinase, being regulated upstream by the small GTPase Ras (1Pearson G. Robinson F. Gibson T.G. Xu B. Karandikar M. Berman K. Cobb M.H. Endocr. Rev. 2001; 22: 153-183Google Scholar, 2Marshall C.J. Curr. Opin. Genet. Dev. 1994; 4: 82-89Google Scholar). It has been proposed that the duration and amplitude of ERK signals are determinant in the decision of cell fate (3Qiu M. Green S.H. Neuron. 1992; 9: 705-717Google Scholar, 4Traverse S.N. Gomez N. Paterson H. Marshall C.J. Cohen P. Biochem. J. 1992; 288: 351-355Google Scholar, 5Cowley S. Paterson H. Kemp P. Marshall C.J. Cell. 1994; 77: 841-852Google Scholar). As such, unregulated activation of the ERK pathway is common in human neoplasia, both in solid tumors (6Oka H. Chatani Y. Hoshino R. Ogawa O. Kakehi Y. Terachi T. Okada Y. Kawaichi M. Kohno M. Yoshida O. Cancer Res. 1995; 55: 4182-4187Google Scholar, 7Sivaraman V.S. Wang H. Nuovo G.J. Malbon C.C. J. Clin. Investig. 1997; 99: 1478-1483Google Scholar, 8Hoshino R. Chatani Y. Yamori T. Tsuruo T. Oka H. Yoshida O. Shimada Y. Ari-i S. Wada H. Fujimoto J. Kohno M. Oncogene. 1999; 18: 813-822Google Scholar, 9Davies H. Bignell G.R. Cox C. Stephens P. Edkins S. Clegg S. Teague J. Woffendin H. Garnett M.J. Bottomley W. Davis N. Dicks E. Ewing R. Floyd Y. Gray K. Hall S. Hawes R. Hughes J. Kosmidou V. Menzies A. Mould C. Parker A. Stevens C. Watt S. Hooper S. Wilson R. Jayatilake H. Gusterson B.A. Cooper C. Shipley J. Hargrave D. Pritchard-Jones K. Maitland N. Chenevix-Trench G. Rig-gins G.J. Bigner D.D. Palmieri G. Cossu A. Flanagan A. Nicholson A. Ho J.W. Leung S.Y. Yuen S.T. Weber B.L. Seigler H.F. Darrow T.L. Paterson H. Marais R. Marshall C.J. Wooster R. Stratton M.R. Futreal P.A. Nature. 2002; 417: 949-954Google Scholar) and in hemopoietic malignancies (10Towatari M. Iida H. Tanimoto M. Iwata H. Hamaguchi M. Saito H. Leukemia (Baltimore). 1997; 11: 479-484Google Scholar, 11Kim S.C. Hahn J.S. Min Y.H. Yoo N.C. Ko Y.W. Lee W.J. Blood. 1999; 93: 3893-3899Google Scholar, 12Milella M. Kornblau S.M. Estrov Z. Carter B.Z. Lapillonne H. Harris D. Konopleva M. Zhao S. Estey E. Andreeff M. J. Clin. Investig. 2001; 108: 851-859Google Scholar). Thus, much attention is currently being focused on the ERK pathway as a potential target for antineoplasic therapy (13Lee Jr., J.T. McCubrey J.A. Leukemia (Baltimore). 2002; 16: 486-507Google Scholar). The role of ERKs in hemopoiesis and leukemogenesis is a hot field of research. It is now widely documented that ERKs play an essential role in proliferation and differentiation in many cell types (5Cowley S. Paterson H. Kemp P. Marshall C.J. Cell. 1994; 77: 841-852Google Scholar, 14Pages G. Lenormand P. L'Allemain G. Chambard J.C. Meloche S. Poyssegur J. Proc. Natl. Acad. Sci. U. S. A. 1993; 90: 8319-8323Google Scholar, 15Brunet A.G. Pages G. Poyssegur J. Oncogene. 1994; 9: 3379-3387Google Scholar, 16Mansour S.J. Matten W.T. Hermann A.S. Candia J.M. Rong K. Fukasawa G.W. Vande Wounde G.F. Ahn N.G. 1994; Scholar, E. Y. S.J. E. J. Scholar, W. C. R. A. Pages G. R. J. Scholar, H. E. E. V. J. 1997; Scholar, T. S.T. J. 1995; Scholar). in the hemopoietic is also well known that ERKs are pivotal elements in the processes regulated by in hemopoiesis Blood. Scholar). in the of proliferation and differentiation in cells of is not this on cell that ERK activation is critical for proliferation and differentiation S.C. P. Ahn N.G. Cell. 1997; Scholar, K. S. J. 1997; Scholar, A.S. J.W. Blood. 1997; 90: Scholar, O. Blood. 2001; Scholar). that cells and of the of activation of the ERK pathway (10Towatari M. Iida H. Tanimoto M. Iwata H. Hamaguchi M. Saito H. Leukemia (Baltimore). 1997; 11: 479-484Google Scholar, M. M. A. Iida H. H. Y. Tanimoto M. Saito H. T. Leukemia (Baltimore). 1999; Scholar, N. E. C. J. P. J. Scholar). key in the upbringing of is the unregulated of signals that promote survival and/or of or cells be this of evidence that the the and duration of signals by the MAPK modules is a determinant in the decision a cell or apoptosis (1Pearson G. Robinson F. Gibson T.G. Xu B. Karandikar M. Berman K. Cobb M.H. Endocr. Rev. 2001; 22: 153-183Google Scholar). cell types the activation of ERKs a survival Thus, the ERKs pathway has to be an to cells apoptosis J.S. Oncogene. Scholar, B.A. J. 2001; Scholar). by the of MEK1/2 S.J. S.J. Proc. Natl. Acad. Sci. U. S. A. 1995; W.J. F. P.A. J.M. J. and J.S. R. K. A. H. A. S. 1999; has been as a to the effects of including W. J.C. Clin. Cancer Res. 1999; Jr., R. P. S. and S. A. P. S. Biochem. Scholar). this the of ERK activity has been to be effective in apoptosis in chronic myelogenous leukemia cell by acting in the C. G. R. M. P. S. Cancer Res. 2002; a inhibitor for the protein kinase present in of S. E. S. S. J. Scholar, M. B. E. J.M. H. R. S. N. J. 2001; Scholar). the molecular by which ERK activity have an on Bcr-Abl are a large of the of the ERK pathway in the conveyance of survival is known the components and molecular activated ERKs To ERK substrates have been including protein kinases, factors, factors, and These are distributed in cellular the nucleus, cytoplasm, and (1Pearson G. Robinson F. Gibson T.G. Xu B. Karandikar M. Berman K. Cobb M.H. Endocr. Rev. 2001; 22: 153-183Google Scholar). The biological consequences of ERK activity to these distinct cellular locations and relative contribution to ERKs survival signal are To this end, the of for constitutively activated ERK2 to the nucleus or to the cytoplasm, we have the consequences of ERK activation on to distinct stimuli in we demonstrate that the protective effects of ERK2 against distinct apoptogenic stimuli are dependent on the cellular localization where activation this we present evidence suggesting that to apoptosis nuclear ERK activity we present that the the of ERK2 and of the complex as a to cell on the causative apoptogenic stimulus. were in from from a from cell growth and cell were by and as activity of by of to is by or an and that are a of for and ERK forms M.J. E. Cobb M.H. Curr. Scholar) were in to cells by a cells were for and were by and cells were for the cells were and in DTT, and were by and were by or and and and were from and were from from kinase activities were in as V. B. P. Cell. Scholar) by myelin basic protein or as were on by in PBS, in for and for were for for and serum in for were in PBS, for the and for the to were in to and a of were by as R. S. R. J.C. Dev. 1997; 11: Scholar). of from or cells were a the as A. C. M. P. J. Biochem. Res. 1999; Scholar). to the of cells were in and The cytoplasmic of the by to and K. were by and and in of to the cell by the as H. H. T. R. Proc. Natl. Acad. Sci. U. S. A. 1997; Scholar). cells were in DTT, and in DTT, The and to the cytoplasmic as were in DTT, on and and the cell ERKs to cell Blood. Scholar) is a for cell is to apoptosis A. R. M. Green T.G. Blood. 1994; Scholar, S. J.S. P.A. A. S.H. Blood. 1997; 90: a to the of Bcr-Abl A. B.A. S.J. Blood. 1994; Scholar, B.A. Res. Scholar). cells be induced to apoptosis by such as C. G. R. M. P. S. Cancer Res. 2002; Scholar) and Yoo S.H. Res. Scholar). both apoptosis a on ERK activation to ERK activity apoptosis in CML, we to the ERK activation and to as for a in cell this we utilized and cell and for we also the leukemia cell these cell ERK activity growth cell of or N. E. C. J. P. J. Scholar) not were ERK activity were in the cell the ERK activity those in and which ERK activation We also the to apoptosis of these cell To this end, cells were of serum for a prolonged and It that the cell that the ERK activity the to apoptosis caused by of growth factors, as of serum On the other hand, in and that ERK activity of the of The cell in which ERK activity were the the to serum apoptosis and by the It has been show that of the ERK pathway by MEK1/2 is a of apoptosis in cells Yoo S.H. Res. Scholar, W. Res. 2001; Scholar). Thus, we if this a in cells of the cell As such, and cells were in the or of the inhibitor and apoptosis As in in cells of ERK activation in an in of growth factor and the of starvation, that the activity of ERK the results were in the of not these results that ERK activity and to apoptosis in cell ERK but to the biological effects of ERK activity to restricted cellular this we utilized for ERK2 in this ERK2 constitutively active M.J. E. Cobb M.H. Curr. Scholar). were utilized as which to the cytoplasm, and a form in which in nuclear signal been to a localization to the nucleus M.J. E. Cobb M.H. Curr. Scholar). These not the of this protein to and phosphorylate in ERK such as and as as cells were these and were on the of to To of were for and to form a in which the expression of the the of the that these were We to the location of the by As in a mainly restricted to the On the Furthermore, whereas of the in of the nuclear factor the cytoplasmic not not Thus, in results M.J. E. Cobb M.H. Curr. the compartmentalized cellular of these activated forms of results from that cells in a fashion of ERK activation N. E. C. J. P. J. Scholar). As such, we to of ERK activation to defined cellular locations alter this we the growth of the and we also a a constitutively active N. E. C. J. P. J. Scholar). As in the growth of these cell a of neither nor in to that neither ERK as induced by nor ERK2 restricted to the nucleus or to the cytoplasm, proliferation in The to investigate if compartmentalized ERK2 activation an on cell survival. to we the of the aforementioned cell serum It that the cell to a to the of starvation, but from that cells and a in the number of the number of cells in those and proliferation and a in cell It to the survival in the cell dependent on the ERK2 kinase activity by the To we generated a cell an ERK2 kinase in which ERK2 the in the M.J. E. Cobb M.H. Curr. Scholar). this cell that of the were of being to as not the number of cells in the to a to that one in cells these that compartmentalized activation of ERK2 not the proliferation of but a on cell survival on the localization where ERK activation ERK2 on of the we the cell survival in and cell by the of growth serum in a on the activation of ERKs Thus, be that on the where ERK activation As such, the cell the activated ERK2 were subjected to serum for and apoptosis by As in in and apoptosis to these in cells the of apoptosis much of also To this we also the of apoptosis by other As such, of and the of cells These results the that against apoptosis induced by growth factor mainly by the activation of ERK2 in the It to the of cytoplasmic ERK2 activation a of the in against other apoptogenic stimuli the response in other cellular To this end, we the effects of compartmentalized ERK2 activation against the known to be a of apoptosis in cells S. M. Tsuruo T. Scholar). results C. G. R. M. P. S. Cancer Res. 2002; Scholar, S. M. Tsuruo T. of cells in a of activated ERK2 and a both by and by of Most to apoptosis in On the other hand, in cells in which ERK2 activation is restricted to the nucleus, the of apoptosis against also in the cell E. we also the effects of compartmentalized ERK2 activation against of cells UV not in on the activity of ERKs Most to apoptosis induced by UV in cells where activation of ERK2 restricted to the or to the nucleus a protective be in in which ERK activation These results on the in the protective response by ERKs takes in distinct cellular to to the of a cell to defined apoptogenic stimuli be by the of ERK activation a To this we and cell for to and to apoptosis both by and by As in that the to apoptosis and cell by the of On the other hand, the to apoptosis the to that by and were the of and been the and we the to by the cell have of activated ERKs present nuclear To we for the cell These nuclear and cytoplasmic as by against and as nuclear and cytoplasmic We the of ERK in these Most in the of activated ERKs present in the cytoplasm, and be in the nucleus, in the of this cell to On the other hand, in which the to of ERKs were present in the cells that an to of activated ERKs were These results in of ERK nuclear activity a role in the of cells to apoptosis by ERK2 on the and the to an the activated ERK apoptosis in Thus, we compartmentalized ERK2 activation pathways known to effects in cellular of the J. H. E. J. S.J. Cell. Scholar). is by the pathway S. A. M. Jr., D. Oncogene. 1999; 18: Scholar) the of we by ERK2 on were and and cell not the we also the in the of the factor CREB, known to in being by the ERK pathway S. Neuron. Scholar). we not on not well known in processes in cell types is the factor G.R. 2002; Scholar). As such, we signaling pathways were activated as a of compartmentalized ERK2 activity and mediated in the effects of To if were as a response to ERK2 activation apoptogenic we an and As in were present in and as well as in cells and these cell to serum not in the of the in the of the from cells and from in which this On the other hand, in and cells in which we a to apoptosis To the of in ERK we if by we alter the protective effects that nuclear ERK2 activation against To this end, we utilized the inhibitor known to by J.W. R. G. J. T. J. 1997; Scholar). As we in to control in the of apoptosis induced by of the to apoptosis the by the in these this a It of to the protective of against apoptosis in the cellular location in which ERK2 we the in cells in which ERK2 is active in the this of not the caused by we if the of also ERK2 protective effects against apoptosis induced by other stimuli. We this in cells in which we have that ERK2 against serum As in in the of apoptosis caused of serum by the the inhibitor all, these results that the overall effects on apoptosis from the ERKs and activities is strictly dependent on the cellular where ERK2 activation and the is in the of the activation of ERKs in and differentiation processes in cells is a currently a large of the of ERKs in the of survival and/or signals in these cells Blood. Scholar). As such, be that those cells that exhibit ERK activity against apoptogenic stimuli. this has been in cells of Yoo S.H. Res. Scholar). we demonstrate that also to cell is that ERK activity and to apoptosis not a the in ERK activity and cells are not but much to apoptosis for this be that of a in to apoptosis as a of ERK activity be a of ERK activation which to apoptosis is this has been that the activity of ERKs by the of such as and to apoptogenic stimuli Yoo S.H. Res. Scholar, W. Res. 2001; Scholar). we show that this is also the for other cell such as and in which to serum It be that in of the aforementioned the effects of the are be by the known that the of these to activation is in which is A. Cohen P. J. 1995; as is the in Thus, is that the effects on apoptosis of the ERK pathway be the results of be to the activity of ERKs and a large of evidence that the of the ERK is the the of the ERK and the signals that the of a cell to apoptosis (1Pearson G. Robinson F. Gibson T.G. Xu B. Karandikar M. Berman K. Cobb M.H. Endocr. Rev. 2001; 22: 153-183Google Scholar). of the role of ERKs in cell survival we have an in the consequences of ERK activity in the response of cell It is well that activated ERKs throughout the cell and phosphorylate that are distributed in (1Pearson G. Robinson F. Gibson T.G. Xu B. Karandikar M. Berman K. Cobb M.H. Endocr. Rev. 2001; 22: 153-183Google Scholar, M. M. Y. E. J. 1997; Scholar, A. D. Lenormand P. S. S. J. J. 1999; 18: Scholar). ERKs regulate processes in a but not cytoplasmic ERK signaling is for activation of by growth factor A. F. S.M. A. J. 2001; Scholar). ERKs are to processes strictly dependent on cellular as we have V. B. P. Cell. Scholar). is that the relative of these ERK signal components to a biological are is by evidence that ERK activation restricted to the nucleus is to differentiation in cells and of M.J. E. Cobb M.H. Curr. Scholar). ERK nuclear and proliferation F. G. A. B. F. Cell. 1999; Scholar, E. J.W. M. J.C. B. J. M.H. H. Dev. Cell. 2001; Scholar). we demonstrate that the effects of ERK also be in a on the apoptogenic stimulus. As such the protective against growth factor is by cytoplasmic ERK, whereas the response against takes in the in cells ERK in the of cells J.M. S. Cell. 2002; 22: and results that a protein that activated ERK in the cytoplasm, factor apoptosis in F. E. H. Biochem. Scholar). On the other hand, we show that ERK of is to apoptosis induced by stimuli such as UV as a of the apoptogenic response against this of being by processes that from we demonstrate that in cells activation of ERKs is by serum or by but is by UV light. The of the to defined apoptogenic stimuli and compartmentalized ERK activity be in a this of the of active ERKs the nucleus and the of cell such a We show that in cell that exhibit ERK activity and the one that of activated ERK the cytoplasm, is to apoptosis caused by growth factor On the other the one that of activated ERK the nucleus, is to the of these cells have the ERK activity those of and and the of ERK activity nuclear and cytoplasmic are also the Thus, cells are the to apoptosis induced both by serum and by STI571. The nuclear ERK activity and to apoptosis from has and results this these have been a number of Thus, of the aforementioned the of a number of We have to a the of the mediators that on ERK2-mediated survival in processes J.M. Dev. we have not been to on the of or of dependent on ERK survival this demonstrate that cells not A. A. M. J. Leukemia (Baltimore). 1997; 11: suggesting that the pathway play a role in processes in these On the other hand, we demonstrate a the to apoptosis and the of as a of nuclear ERK2 the of not to be to against apoptosis caused by serum starvation, of the activation of It is well known that Bcr-Abl and the in this is not is known to be for Bcr-Abl effects M. M.H. J.C. Oncogene. 1997; Scholar, G.W. D. Jr., A.S. Dev. Scholar). As such, in cells as cells in the of nuclear but not cytoplasmic ERK activity is results that an upstream of the in Bcr-Abl effects through activation R. T. Y. K. T. Y. Oka Y. Y. Oncogene. 22: Scholar). Furthermore, has been that activation of takes as a of the of by the ERK G.J. S.T. A. M. J.C. A. J. 1997; 16: Scholar, J. 1997; Scholar). activation takes both in the nucleus and the M. S. Cell. 1999; results that nuclear be of be that in and of the nucleus S. A. M. Cell. 18: Scholar, S. Cell. 2001; Scholar). that the inhibitor the protective effects of nuclear ERKs against These results the role of as a of survival signals for nuclear by that is not a inhibitor of but is an inhibitor of J.W. R. G. J. T. J. 1997; be It is that nuclear ERK2 by a of Thus, not nuclear Such a is not a V. J. A.S. J. Scholar) that activation of by Bcr-Abl an pathway of It is that the of by has other effects of this has been that through an P. S. C. M. J. J. V. A. J. Scholar). play an role in the of apoptosis C. C. an be one in through nuclear ERK2 this this of ERK2 being active in the nucleus, on Bcr-Abl is active or a the mediators have yet to be results demonstrate for the that the protective response of ERKs against defined apoptogenic stimuli is dependent on the cellular localization where ERK activation We are to M. H. Cobb for the and to for STI571.

References

70